• Home
  • About Us
  • Blog

Pulmonary Hypertension RN

  • What is Pulmonary Hypertension?
    • What is Pulmonary Hypertension?
    • Pulmonary Hypertension Symptoms
    • Types of Pulmonary Hypertension
    • Causes of Pulmonary Hypertension
    • PH vs. PAH
    • Diastolic Heart Failure vs. PAH
    • WHO Group 3 Pulmonary Hypertension, IPF & COPD
    • Pulmonary Veno-Occlusive Disease
    • Hereditary Hemorrhagic Telangiectasia (HHT)
      • Hereditary Hemorrhagic Telangiectasia (HHT) Treatment
    • Functional Classification of Pulmonary Hypertension
    • Congenital Heart Disease
      • Eisenmenger’s Syndrome
      • Update on Management of PAH-CHD
      • Congenital Heart Disease & Sleep Apnea
      • Complex Congenital Heart Disease
      • Atrial Septal Defect and Pulmonary Arterial Hypertension
    • Pediatric Pulmonary Arterial Hypertension
    • Sickle Cell and Pulmonary Hypertension
    • Stimulant Associated Pulmonary Arterial Hypertension
    • Porto-Pulmonary Syndrome
    • Research, Life Expectancy & Prognosis for PH
  • Diagnosing & Monitoring PAH
    • Pulmonary Arterial Hypertension Diagnosis
    • How Am I Doing? Assessing Your PAH.
    • Blood Tests
    • Cardiopulmonary Exercise Test (CPET)
    • CT (Computed Tomography) Scan
    • Echocardiogram: An Overview
    • Echocardiogram: A Detailed Look
    • Pulmonary Function Tests (PFTs)
    • Right Heart Catheterization
    • Six Minute Walk
    • Ventilation Perfusion Scan (VQ Scan)
    • CTEPH
      • CTEPH: WHO Group 4 Pulmonary Hypertension
      • PTE (Pulmonary Thromboendarterectomy) Surgery
      • Adempas used to Treat PAH and CTEPH
  • PAH Treatment
    • Pulmonary Hypertension Centers
    • Pulmonary Hypertension Treatments
    • Continuously Infused Therapies Used to Treat PH
    • Prostanoids for Treatment of PH
    • Adcirca and Revatio Used to Treat Pulmonary Arterial Hypertension (PAH)
    • Adempas used to Treat PAH and CTEPH
    • Tracleer, Letairis, and Opsumit Treatments
    • Oxygen Therapy for Pulmonary Hypertension
    • Salt and Water Restrictions
    • Exercise & PAH
    • Diuretics
    • Blood Thinners
    • Getting the Most Out of PAH Therapy
      • Letairis
      • Opsumit
      • Sildenafil (Revatio)
  • Research
  • FAQ’s
    • Implanted Remodulin Pump, Right Heart Catheterization, PAH & Pregnancy
    • Oral Treatments, Care Centers & Hole in Heart
    • FAQ’s: Altitude, Cold & Allergy Medications
    • FAQ’s: Psoriasis, Idiopathic PAH, Contraceptives & PAH
    • FAQ’s: Causes of Pulmonary Hypertension, Symptom Frequency & Care Centers
    • FAQ: PAH Experts, Pregnancy, Mild PAH & Vacationing
    • FAQ’s: CTEPH, Blood Clots, Corrective Surgery & PAH Care Centers
    • FAQ’s: VQ Scans & PAH Curable?
    • FAQ’s: Mild Pulmonary Hypertension?
    • FAQ’s: Boating, Swimming & Eating with PAH
    • FAQ’s: Borderline Pulmonary Hypertension, Hand Swelling, Children with PAH, Costs

Getting the Most from the Holiday Season with PAH

December 16, 2019 By Dr. Jeremy Feldman

holiday celebration

The holidays are a time to spend with family and friends and reflect on the past year and think about the upcoming year.  This sounds wonderful and low stress.  Nothing could be further from the truth. For many people the holiday season is a particularly stressful time of year.  While connecting with family can be enjoyable, sometimes our mental … [Read more...]

Pulmonary Hypertension Due To Valvular Heart Disease

October 29, 2019 By Dr. Jeremy Feldman

heart valves in pulmonary hypertension

As a quick refresher, remember that Pulmonary Hypertension is broadly divided into five groups: Group 1:  Pulmonary Arterial Hypertension Group 2:  PH due to left heart disease and valvular heart disease Group 3:  PH due to chronic lung disease (pulmonary fibrosis or emphysema) Group 4:  PH due to chronic blood clots Group 5:  PH due to various miscellaneous … [Read more...]

A New Approach to Treating Pulmonary Arterial Hypertension

October 23, 2019 By Dr. Jeremy Feldman

pulmonary hypertension research laboratory

Historic Treatment of Pulmonary Hypertension  For 30 years the focus of treating PAH has been finding medications that dilate (or relax) the pulmonary arteries.  This approach has served patients well.  The prognosis for patients diagnosed today with PAH is very different from 30 years ago.  Today patients can expect to take usually two if … [Read more...]

Scleroderma: Screening for Pulmonary Hypertension

October 10, 2019 By Dr. Jeremy Feldman

PAH Physician

Co-Authored By: Dr. Akshay Muralidhar Scleroderma is part of a special group of diseases called connective tissue diseases.  This group of diseases includes lupus, rheumatoid arthritis, mixed connective tissue disease and many others.  A key feature of these diseases is that the disease may involve multiple parts of their body including skin, joints, … [Read more...]

Salt, the Hidden Enemy

August 21, 2019 By Dr. Jeremy Feldman

Salt restrictions for PH patients

Salt is necessary for life. Without any salt our bodies are unable to work properly. However, in modern society the pendulum has swung very far towards excessive salt in our diet.  As the world’s population has shifted from a rural setting towards cities, our diets have changed dramatically.  Prepared foods and processed foods now occupy a large part of … [Read more...]

« Previous Page
Next Page »

PAH Life Expectancy

PAH Research

Research, Life Expectancy & Prognosis for PH

Major Developments in Pulmonary Hypertension Affecting Prognosis 1.     Approval of

Where to Get Treatment?

CCCs for PAH

Pulmonary Hypertension Centers

Where to get treatment for pulmonary hypertension? Pulmonary arterial hypertension is a

Popular Posts

VQ perfusion lung scan severe pulmonary hypertension CTEPH

FAQ’s: VQ Scans & PAH Curable?

By Dr. Jeremy Feldman

Ventilation Perfusion Lung Scans Ventilation perfusion lung scans or VQ scans are an important test to evaluate for the

update

Acceleron Announces a Positive Trial

By Dr. Jeremy Feldman

PULSAR Phase 2 Study Results This was a very exciting week in the world of pulmonary arterial

good news in pah

 

Disclaimer

Recent Blog Posts

  • In Memoriam:  Greg Ahearn, MD June 16, 2024
  • Sotatercept (Winrevair) Approved! June 1, 2024
  • Disappointing News for Rodatristat Ethyl October 11, 2023

Categories

Archives